Aditxt earnings were -$42.2M for the trailing 12 months ending Sep 30, 2025, with -89.6% growth year over year. The latest ADTX earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$24.0M, up 231.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ADTX reported annual earnings of -$46.3M, with 40.1% growth.
ADTX past earnings growth
How has ADTX's earnings growth performed historically?
Aditxt (NASDAQ: ADTX) reported Q3 2025 earnings per share (EPS) of -$548.78, up 99.98% year over year. Total ADTX earnings for the quarter were -$24.05 million. In the same quarter last year, Aditxt's earnings per share (EPS) was -$3,137,695.20.
As of the last Aditxt earnings report, Aditxt is currently losing money. Aditxt's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$42.24 million, a 8.67% decrease year over year.
What was ADTX's earnings growth in the past year?
As of Aditxt's earnings date in Q1 2026, Aditxt's earnings has grown -89.56% year over year. This is 149.43 percentage points lower than the US Biotechnology industry earnings growth rate of 59.87%. ADTX earnings in the past year totalled -$42.24 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.